Clinical Trials Browser

Neurologic Manifestations × Temozolomide × Sarcoma × Clear all

NCT00365222 2009-01-22

Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma

Phase 2 Terminated

Brain Neoplasms, Glioblastoma, Neurologic Manifestations, Gliosarcoma